Abstract

Background: Detailed nailfold capillary abnormalities have not been described in mixed connective tissue disease (MCTD) as well as their changes over time, unlike systemic sclerosis (SSc) which microvascular damage has been classified and validated by nailfold videocapillaroscopy (NVC) in specific and progressive scleroderma patterns (“Early”, “Active”, “Late”) (1-5). Objectives: Aim of this study was to retrospectively compare detailed MCTD nailfold capillary abnormalities with those of SSc patients at first visit, and to monitor MCTD capillary changes over time. Methods: Ten patients (mean disease duration 6.4±4.2 years, mean age 50±19 years,) affected by MCTD (Kasukawa’s criteria) were enrolled. Patients with either anti-extractable nuclear antigen positivity different from U1RNP or anti-dsDNA antibodies were excluded. Main capillary parameters (scores of enlarged capillaries, giant capillaries, microhemorrhages, capillary ramifications, as well as absolute number of normal and total capillaries per linear millimetre) were assessed in MCTD patients at their first NVC analysis (T0), and during a three year follow-up. Furthermore, NVC parameters were compared at T0 with 10 random SSc patients matched for disease duration (6.4±4.2 years) and age (51±17 years). Statistical analysis was performed by non parametric tests. Results: The capillaroscopic scores of enlarged capillaries, giant capillaries and microhemorrhages were found significantly higher in SSc versus MCTD patients at T0 (2.50±0.5 vs 1.90±0.6 p=0.04, 1.63±0.7 vs 0.70±0.7 p Conclusion: In a limited cohort of MCTD patients with an average disease duration of 6.4 years and a follow-up of three years, the nailfold microvascular damage does not seem to be significantly progressive. Patients with MCTD seem to show less enlarged/giant capillaries, and larger absolute number of total and normal capillaries than SSc patients.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.